1247 TRISOMY CIC

Company limited by guarantee

Company Registration Number:
15357464 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 18 December 2023

End date: 31 December 2024

1247 TRISOMY CIC

Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report
Balance sheet
Additional notes
Community Interest Report

1247 TRISOMY CIC

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Principal activities of the company

The principal activity of the company during the year was to prepare for future community projects supporting individuals and families affected by Trisomy conditions. The company has remained dormant during this period.

Additional information

2. Business review / community impact No trading has taken place. Preparatory work has focused on developing project plans, identifying funding opportunities, and liaising informally with stakeholders to understand community needs. These steps will enable the company to deliver meaningful community impact once funding is secured. 3. Directors’ remuneration No directors have received any remuneration during the financial year. 4. Dividends No dividends have been declared or paid. 5. Statement of directors’ responsibilities The directors are responsible for preparing the accounts in accordance with applicable law and regulations. The directors confirm that the company was dormant throughout the financial year and that the accounts give a true and fair view of the company’s state of affairs.



Directors

The director shown below has held office during the whole of the period from
18 December 2023 to 31 December 2024

Jordan Dunkley-Dixon


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
15 September 2025

And signed on behalf of the board by:
Name: Jordan Dunkley-Dixon
Status: Director

1247 TRISOMY CIC

Balance sheet

As at 31 December 2024

Notes 2024


£
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 0
Investments:   0
Total current assets: 0
Prepayments and accrued income: 0
Creditors: amounts falling due within one year:   0
Net current assets (liabilities): 0
Total assets less current liabilities: 0
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 0
Members' funds
Profit and loss account: 0
Total members' funds: 0

The notes form part of these financial statements

1247 TRISOMY CIC

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 15 September 2025
and signed on behalf of the board by:

Name: Jordan Dunkley-Dixon
Status: Director

The notes form part of these financial statements

1247 TRISOMY CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

1247 TRISOMY CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    2024
    Average number of employees during the period 0

COMMUNITY INTEREST ANNUAL REPORT

1247 TRISOMY CIC

Company Number: 15357464 (England and Wales)

Year Ending: 31 December 2024

Company activities and impact

During this financial year the company has not commenced trading and is therefore filing dormant accounts. While no direct community activities were delivered, the directors have focused on developing plans and seeking funding to support future projects for individuals and families affected by Trisomy conditions. This preparatory work ensures that once funding is secured, the company will be able to provide meaningful support, raise awareness, and create resources that will directly benefit the community.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
15 September 2025

And signed on behalf of the board by:
Name: Jordan Dunkley-Dixon
Status: Director